Soft Tissue Lesion clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • PET [89Zr]DFO-starPEG in Solid Tumors

    open to eligible people ages 18 years and up

    This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and retention (EPR)-mediated tracer uptake before administration of EPR-based nanomedicines.

    San Francisco, California

Our lead scientists for Soft Tissue Lesion research studies include .

Last updated: